1CM
CDMO

1492 Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

1492 Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-57,928
Closed -$388K – 110
2024
Q1 		$388K Buy
+57,928
New +$399K 0.22% 69

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

1492 Capital Management's CDMO Position: Q2 2024 in Review

1492 Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2024, closing a stake of 57,928 shares — an estimated $388K sold.

1492 Capital Management first reported a position in CDMO in Q1 2024 and held it in 1 quarter. The position peaked at $388K in Q1 2024. 171 funds tracked by Wall St. Rank hold CDMO as of Q2 2024.

  • 1492 Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • 1492 Capital Management sold 57,928 Avid Bioservices, Inc. Common Stock shares in Q2 2024, an estimated $388K.
  • 1492 Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
  • 1492 Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $388K in Q1 2024.
  • 171 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2024.

Based on 1492 Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.